SCHEMBL3575940

SCHEMBL3575940

CC(C)(C)c1cc(-c2nc(C3CCNCC3)cs2)cc(C(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 6/20 0.42
HRH4 Q9H3N8 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
TMIGD3 P0DMS9 1/20 0.35
ADORA1 P30542 1/20 0.35
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
SHMT1 P34896 1/20 0.33
SHMT2 P34897 1/20 0.33
HPGDS O60760 1/20 0.33
EP300 Q09472 2/20 0.33
TGFBR1 P36897 1/20 0.33
TLR9 Q9NR96 1/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3588524 0.86 HTR2C (0.44) PLATHRH4MEN1POLBKMT2A
SCHEMBL3583375 0.86 GABRA1 (0.43) PLATGABRA1GABRG2GABRB3EP300
SCHEMBL3587587 0.86 PLAT (0.36) PLATGABRA1GABRG2GABRB3MEN1
SCHEMBL3588162 0.83 PTGS1 (0.41) PLATCNR1CNR2
SCHEMBL3580316 0.81 PTGS2 (0.43) PLATHRH4TMIGD3ADORA1GABRA1
SCHEMBL3578450 0.79 PLAT (0.45) PLATHRH4GABRA1GABRG2GABRB3
SCHEMBL13422220 0.78 HPGDS (0.52) PLATHRH4CNR1CNR2MEN1
SCHEMBL3576329 0.77 MEN1 (0.57) PLATMEN1POLBKMT2ATLR7
SCHEMBL3579579 0.76 HTR2C (0.51) PLATMEN1POLBKMT2A
SCHEMBL2300164 0.76 HPGDS (0.51) PLATGABRA1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators CXCR3, CXCR1, CXCR2 PLAT 2714/4885HRH4 605/4885CNR1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.